Top

World Journal of Surgery

Published in:

01-09-2009

Metastasis-Associated Protein 1 (MTA1) Overexpression is Closely Associated with Shorter Disease-Free Interval After Complete Resection of Histologically Node-Negative Esophageal Cancer

Authors: Shu-Hai Li, Zhou Wang, Xiang-Yan Liu

Published in: World Journal of Surgery | Issue 9/2009

Abstract

Background

The purpose of the present study was to investigate the expression of metastasis-associated protein 1 (MTA1) and its relationship to the disease-free interval after resection of pathologic N0 (pN0) esophageal squamous cell cancer (ESCC).

Methods

The subjects were 90 patients who successfully underwent complete resection of pN0 ESCC between May 2001 and May 2003. Immunohistochemical staining for MTA1 protein was performed using the avidin–biotin peroxidase complex method. Log-rank test was performed to compare the disease-free interval, and Cox regression multivariate analysis was performed to judge independent prognostic factors.

Results

Metastasis-associated protein 1 overexpression was detected in 40 esophageal cancer tissues. Disease-free interval was significantly associated with MTA1 protein overexpression (p = 0.015). The overall 5-year survival rate was 45.6%, the 5-year survival rate of patients with MTA1 protein overexpression was significantly lower than that of those without overexpression (25.0 versus 62.0%; p < 0.001). The results of multivariate analysis confirmed that T status and MTA1 protein overexpression were independent prognostic factors.

Conclusions

Metastasis-associated protein 1 overexpression was detected in pN0 ESCC and was significantly correlated with shorter disease-free interval. T status and MTA1 protein overexpression were both independent prognostic factors. These findings suggested MTA1 might be a predictor of relapsing phenotype and a prognostic factor in esophageal cancer.

Japanese Society of Esophageal Diseases (2005) Long-term results of esophagectomy for esophageal cancer in Japan, 1988–1997. Esophagus 2:1–13CrossRef

Korst RJ, Rusch VW, Venkatraman E et al (1998) Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115:660–670PubMedCrossRef

Visbal AL, Allen MS, Miller DL et al (2001) Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 71:1803–1808PubMedCrossRef

Rice TW, Blackstone EH, Adelstein DJ et al (2001) N1 esophageal carcinoma: the importance of staging and downstaging. J Thorac Cardiovasc Surg 121:454–464PubMedCrossRef

Eloubeidi MA, Desmond R, Arguedas MR et al (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95:1434–1443PubMedCrossRef

Toh Y, Pencil SD, Nicolson GL (1994) A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269:22958–22963PubMed

Toh Y, Pencil SD, Nicolson GL (1995) Analysis of the complete sequence of the novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma and breast cancer cell lines. Gene 159:97–104PubMedCrossRef

Nicolson GL, Nawa A, Toh Y et al (2003) Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer invasion, proliferation and nuclear regulation. Clin Exp Metastasis 20:19–24PubMedCrossRef

Kumar R, Wang RA, Bagheri-Yarmand R (2003) Emerging roles of MTA family members in human cancers. Semin Oncol 30:30–37PubMedCrossRef

10.

Mazumdar A, Wang RA, Mishra SK et al (2001) Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor. Nat Cell Biol 3:30–37PubMedCrossRef

11.

Yan C, Wang H, Toh Y et al (2003) Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J Biol Chem 278:2309–2316PubMedCrossRef

12.

Jang KS, Paik SS, Chung H et al (2006) MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancer. Cancer Sci 97:374–379PubMedCrossRef

13.

Martin MD, Hilsenbeck SG, Mohsin SK et al (2006) Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies. Breast Cancer Res Treat 95:7–12PubMedCrossRef

14.

Hofer MD, Kuefer R, Varambally S et al (2004) The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64:825–829PubMedCrossRef

15.

Balasenthil S, Broaddus RR, Kumar R (2006) Expression of metastasis-associated protein 1 (MTA1) in benign endometrium and endometrial adenocarcinomas. Hum Pathol 37:656–661PubMedCrossRef

16.

Ryu SH, Chung YH, Lee H et al (2008) Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma. Hepatology 47:929–936PubMedCrossRef

17.

Mahoney MG, Simpson A, Jost M et al (2002) Metastasis-associated protein (MTA) 1 enhances migration, invasion and anchorage-independent survival of immortalized human keratinocytes. Oncogene 21:2161–2170PubMedCrossRef

18.

Hofer MD, Menke A, Genze F et al (2004) Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. Br J Cancer 90:455–462PubMedCrossRef

19.

Toh Y, Ohga T, Endo K et al (2004) Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110:362–367PubMedCrossRef

20.

Chen G, Wang Z, Liu XY et al (2007) Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor Lewis esophagectomy. World J Surg 31:1107–1114PubMed

21.

Nawa A, Nishimori K, Lin P et al (2000) Tumor metastasis-associated human MTA1 gene: its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides. J Cell Biochem 79:202–212PubMedCrossRef

22.

Li SH, Wang Z, Liu XY et al (2007) Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer. Surg Today 37:1047–1052PubMedCrossRef

23.

Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543PubMedCrossRef

24.

Raja S, Luketich JD, Kelly LA et al (2002) Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg 123:475–482PubMedCrossRef

Title: Metastasis-Associated Protein 1 (MTA1) Overexpression is Closely Associated with Shorter Disease-Free Interval After Complete Resection of Histologically Node-Negative Esophageal Cancer
Authors: Shu-Hai Li
Zhou Wang
Xiang-Yan Liu
Publication date: 01-09-2009
Publisher: Springer-Verlag
Published in: World Journal of Surgery / Issue 9/2009
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-009-0119-y

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Metastasis-Associated Protein 1 (MTA1) Overexpression is Closely Associated with Shorter Disease-Free Interval After Complete Resection of Histologically Node-Negative Esophageal Cancer

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2009

Technique of Antroduodenectomy Without Ulcer Excision as a Safe Alternative Treatment for Bleeding Chronic Duodenal Ulcers

Use of a Trauma Service Clinical Pathway to Improve Patient Outcomes for Retained Traumatic Hemothorax

Radiofrequency Ablation for the Treatment of Autonomously Functioning Thyroid Nodules

Clinical Surgery Made Easy: A Companion to Problem-Based Learning, Mohan De Silva

Pancreatic Insulinoma: A Surgical Experience

Ischemic Preconditioning Confers Antiapoptotic Protection During Major Hepatectomies Performed Under Combined Inflow and Outflow Exclusion of the Liver. A Randomized Clinical Trial